Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity
Ana C Almeida1,2,3,4,5, Gabriela A Silva6, Gabriele Santini7
1Department of Ophthalmology, Hospital Beatriz Angelo, Loures, Av. Carlos Teixeira 3, 2674-514, Loures, Portugal. acralmeida@yahoo.com.
Insights
Hyperglycemia, or high blood sugar, is a significant risk factor for retinopathy of prematurity (ROP). Glycated albumin (GlyA) levels were not found to be a significant predictor of ROP in premature infants.
Area of Science:
- Neonatal Medicine
- Ophthalmology
- Endocrinology
Background:
- Retinopathy of prematurity (ROP) is a leading cause of visual impairment in premature infants.
- Hyperglycemia and glycated albumin (GlyA) are potential risk factors for ROP, but their association requires further investigation.
Purpose of the Study:
- To determine the association between hyperglycemia, glycated albumin (GlyA), and retinopathy of prematurity (ROP) in a cohort of premature infants.
- To identify significant risk factors for ROP development.
Main Methods:
- Prospective study of 152 infants requiring ROP screening between March 2017 and July 2019.
- Collected demographic, clinical, and laboratory data, including glucose measurements and serum GlyA levels at multiple time points.
- Employed univariate and multivariate logistic regression analyses to assess risk factors for ROP.
Main Results:
- Thirty-three infants (21.7%) developed ROP.
- Hyperglycemia was present in 72.7% of infants with ROP compared to 0.05% without ROP.
- Multivariate analysis identified hyperglycemia as a significant independent risk factor for ROP (Exp(B) 28.062, p < 0.001), while GlyA was not significant.
Conclusions:
- Hyperglycemia is a critical and independent risk factor for retinopathy of prematurity in premature infants.
- Glycated albumin (GlyA) levels do not appear to be a significant predictor of ROP in this cohort.
- Findings emphasize the importance of glycemic control in preventing ROP.
Abstract:
To determine the association between hyperglycemia, glycated albumin (GlyA) and retinopathy of prematurity (ROP). Prospective study of all infants under ROP screening from March 2017 to July 2019. All demographic, clinical and laboratory data were collected. Glucose was measured at birth and every 8 h for the first week and serum GlyA was evaluated at birth, 1st, 2nd and 4th weeks after birth. Reference range for GlyA was obtained. Univariate logistic regression was used to examine risk factors for ROP followed by multivariate regression. A total of 152 infants were included in the study. Median gestational age was 30 weeks and median birth weight 1240 g. Thirty-three infants (21.7%) had ROP. Hyperglycemia was present in 24 (72.7%) infants diagnosed with any ROP versus 6 (0.05%) in those without ROP. Median GlyA at birth, 1st, 2nd and 4th and respective reference ranges were 8.50% (6.00-12.65), 8.20% (5.32-11.67), 8.00% (5.32-10.00) and 7.90% (5.30-9.00) respectively. After multivariate logistic regression, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors (Exp (B) 28.062, 95% CI for Exp(B) 7.881-99.924 p < 0.001). In our cohort, hyperglycemia but not GlyA, remained a significant risk factor for ROP overpowering the other recognized risk factors.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

